June 3, 2026 · Form 4 insider transaction
Smith Andrew Alasdair bought 200,000 shares of Medicus Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year.